Last $71.57 USD
Change Today +1.99 / 2.86%
Volume 444.4K
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for incyte corp (INCY)

Year over year, Incyte Corporation has been seen their bottom line shrink from a loss of $44.3M USD to an even larger loss of $83.1M USD despite an increase in revenues from $296.6M USD to $354.7M USD. An increase in the percentage of sales devoted to SGA costs from 28.78% to 31.00% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues168.994.0296.6354.7
Other Revenues0.90.50.50.2
TOTAL REVENUES169.994.5297.1354.9
Cost of Goods Sold123.9--0.20.6
GROSS PROFIT46.094.5296.9354.3
Selling General & Admin Expenses, Total32.358.285.4110.0
R&D Expenses--178.7210.4260.4
OTHER OPERATING EXPENSES, TOTAL32.3236.9295.8370.4
OPERATING INCOME13.7-142.51.1-16.1
Interest Expense-43.3-43.8-46.1-38.7
Interest and Investment Income0.50.30.21.3
NET INTEREST EXPENSE-42.8-43.5-45.8-37.3
Other Non-Operating Income (Expenses)0.7------
EBT, EXCLUDING UNUSUAL ITEMS-28.4-186.0-44.7-53.4
Merger & Restructuring Charges0.4------
Gain (Loss) on Sale of Investments0.20.20.6--
Other Unusual Items, Total-4.0-0.7---29.4
Other Unusual Items-4.0-0.7---29.4
EBT, INCLUDING UNUSUAL ITEMS-31.8-186.5-44.1-82.8
Income Tax Expense----0.20.3
Earnings from Continuing Operations-31.8-186.5-44.3-83.1
NET INCOME-31.8-186.5-44.3-83.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-31.8-186.5-44.3-83.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-31.8-186.5-44.3-83.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $71.57 USD +1.99

INCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $6.81 USD +0.15
Array BioPharma Inc $4.64 USD +0.07
Evotec AG €3.65 EUR -0.042
GlaxoSmithKline SAE £12.37 EGP 0.00
Infinity Pharmaceuticals Inc $16.65 USD +0.37
View Industry Companies
 

Industry Analysis

INCY

Industry Average

Valuation INCY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 24.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 22.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.